{"id":"W4388893508","doi":"10.1111/all.15952","title":"Efficacy and safety of abrocitinib in patients with moderate‐to‐severe atopic dermatitis and comorbid allergies","year":2023,"lang":"en","type":"article","venue":"Allergy","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"Pfizer","keywords":"Medicine; Atopic dermatitis; SCORAD; Comorbidity; Placebo; Asthma; Eczema Area and Severity Index; Dermatology Life Quality Index; Adverse effect; Allergy; Dermatology; Internal medicine; Quality of life (healthcare); Immunology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00199079,0.000328095,0.001237185,0.0004391751,0.000303022,0.0006193801,0.0002136285,0.0003006963,0.002780097],"category_scores_gemma":[0.002383435,0.0001444847,0.001650133,0.0007521154,0.0001734705,0.0003420971,0.0002939967,0.0004823433,0.0002477981],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005353175,"about_ca_system_score_gemma":0.0006648515,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005486259,"about_ca_topic_score_gemma":0.00198592,"domain_scores_codex":[0.9989423,0.0003603554,0.0001826229,0.0001906455,0.0002120783,0.0001119016],"domain_scores_gemma":[0.9985672,0.0005219304,0.0006146595,0.00006645853,0.00008761834,0.000142058],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1111727,0.001341865,0.6891325,0.002902589,0.01580743,0.0006359441,0.0001766241,0.001514066,0.008365655,0.0002625983,0.004011226,0.1646769],"study_design_scores_gemma":[0.01651666,0.01528867,0.9481269,0.000333978,0.007474377,0.002974154,0.00011737,0.001169355,0.0014368,0.0004096675,0.006119375,0.00003272685],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9763333,0.01773637,0.0002916163,0.0002185762,0.00003242543,0.0001565909,0.001596607,0.00002172096,0.00361271],"genre_scores_gemma":[0.9970044,0.00141704,0.0001924854,0.0001808074,0.00006264533,0.00008607855,0.0008969817,0.000002772746,0.0001565924],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002780097,"threshold_uncertainty_score":0.01052845,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008535983521442967,"score_gpt":0.2388859951072276,"score_spread":0.2303500115857846,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}